Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 35729005

Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Lung Cancer
Publication date
2022 Nov
First author
Moreno V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Moreno V
      type
      Author
    2. name
      Roda D
      type
      Author
    3. name
      Pikiel J
      type
      Author
    4. name
      Trigo J
      type
      Author
    5. name
      Bosch-Barrera J
      type
      Author
    6. name
      Drew Y
      type
      Author
    7. name
      Kristeleit R
      type
      Author
    8. name
      Hiret S
      type
      Author
    9. name
      Bajor DL
      type
      Author
    10. name
      Cruz P
      type
      Author
    11. name
      Beck JT
      type
      Author
    12. name
      Ghosh S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Moreno V
      type
      Author
    2. name
      Roda D
      type
      Author
    3. name
      Pikiel J
      type
      Author
    4. name
      Trigo J
      type
      Author
    5. name
      Bosch-Barrera J
      type
      Author
    6. name
      Drew Y
      type
      Author
    7. name
      Kristeleit R
      type
      Author
    8. name
      Hiret S
      type
      Author
    9. name
      Bajor DL
      type
      Author
    10. name
      Cruz P
      type
      Author
    11. name
      Beck JT
      type
      Author
    12. name
      Ghosh S
      type
      Author
    bibliography ids
    1. nci-bib-fb1b830166de152bb908d5e1
    book metadata
    content sha256
    3a177b96b6a7e2df1b3bff1ecb49b217bc78a8c989429bbfceb78513eb27660b
    document type
    citation
    dois
    1. 10.1016/j.cllc.2022.05.013
    electronic publication date
    display
    2022 May 23
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35729005
    immutable id
    pubmed:35729005@3a177b96b6a7e2df1b3bff1ecb49b217bc78a8c989429bbfceb78513eb27660b
    journal
    abbreviation
    Clin Lung Cancer
    issn electronic
    1938-0690
    issn print
    1525-7304
    issue
    7
    name
    Clinical lung cancer
    nlm unique id
    100893225
    pages
    e415-e427
    volume
    23
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35729005
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      817f32158d0a46b4a5de425391a253b502d5c02fa8e1eecd8ff432d65132e175
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Nov
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35729005/
      title
      Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice